Onconetix annual operating expenses
2021
2022
2023
2024
2025
Onconetix Operating Expenses Growth & History (ONCO)
Onconetix's operating expenses was $18.5M for fiscal 2025.
View full Onconetix company overviewOnconetix annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $18.5M | −$39.1M | −67.87% |
| 2024 | 2024-12-31 | $57.5M | $22.6M | +64.85% |
| 2023 | 2023-12-31 | $34.9M | $21.4M | +158.93% |
| 2022 | 2022-12-31 | $13.5M | $10.1M | +294.50% |
| 2021 | 2021-12-31 | $3.4M | — | — |
Onconetix quarterly operating expenses
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.7M | $729,172 | +36.35% |
| Q1 2026 | 2026-03-31 | $10.2M | −$2.4M | −18.96% |
| Q4 2025 | 2025-12-31 | $1.5M | −$28.3M | −94.87% |
| Q3 2025 | 2025-09-30 | $2.3M | −$413,145 | −15.02% |
| Q2 2025 | 2025-06-30 | $2.0M | −$11.7M | −85.38% |
| Q1 2025 | 2025-03-31 | $12.6M | $1.3M | +11.94% |
| Q4 2024 | 2024-12-31 | $29.8M | $8.9M | +42.47% |
| Q3 2024 | 2024-09-30 | $2.8M | −$1.7M | −38.70% |
| Q2 2024 | 2024-06-30 | $13.7M | $7.1M | +106.26% |
| Q1 2024 | 2024-03-31 | $11.3M | $8.4M | +295.72% |
| Q4 2023 | 2023-12-31 | $20.9M | $17.7M | +544.54% |
| Q3 2023 | 2023-09-30 | $4.5M | $618,349 | +15.98% |
| Q2 2023 | 2023-06-30 | $6.6M | $2.4M | +54.83% |
| Q1 2023 | 2023-03-31 | $2.8M | $777,598 | +37.55% |
| Q4 2022 | 2022-12-31 | $3.2M | $2.0M | +169.74% |
| Q3 2022 | 2022-09-30 | $3.9M | $2.8M | +253.10% |
| Q2 2022 | 2022-06-30 | $4.3M | $3.5M | +442.10% |
| Q1 2022 | 2022-03-31 | $2.1M | $1.7M | +535.60% |
| Q4 2021 | 2021-12-31 | $1.2M | — | — |
| Q3 2021 | 2021-09-30 | $1.1M | — | — |
| Q2 2021 | 2021-06-30 | $792,274 | — | — |
| Q1 2021 | 2021-03-31 | $325,781 | — | — |
Onconetix operating expenses trends
Between the periods ended 2021-12-31 and 2025-12-31, Onconetix's operating expenses increased from $3.4M to $18.5M, a change of $15.1M. The latest reported quarter, Q2 2026, shows $2.7M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Onconetix source filings ↗